Stem Cell Research for Multiple Sclerosis: Current Scientific Evidence (2026)

Living with multiple sclerosis (MS) means being familiar with a condition that can change over time. While current treatments can help manage symptoms and reduce disease activity in patients. Many patients continue to explore whether ongoing research may lead to new approaches. could lead to new approaches that may better address the underlying disease process. This interest has brought stem cell research into the light, especially for patients looking to understand what current science knows and why it still remains investigational.

In the last ten years, scientists have been studying various methods of utilising stem cells, such as hematopoietic stem cell transplantation and mesenchymal stem cells, to determine whether there is a place for them in treating MS. Some studies have reported encouraging findings in carefully selected patients. However, there are inconsistencies depending on the type of MS, study design, and treatment protocol.

Knowing the most recent scientific findings could be helpful for patients to discuss their health issues with their medical provider and to manage their expectations regarding further treatment.

Why Are Researchers Studying Stem Cell Therapy for Multiple Sclerosis?

Multiple sclerosis is one of the autoimmune conditions, where the body’s immune system mistakenly starts to attack the protective covering (myelin) around nerve fibres in the brain and spinal cord. Although current disease-modifying therapies may help reduce relapse and slow down progression, they may not work as well for every patient or completely stop disease progression. This has led researchers to investigate whether stem cell-based approaches may offer an additional approach to manage the disease.

In 2026, current research focuses on different scientific questions rather than proving a treatment. Researchers are studying whether stem cell therapy may:

Reset Abnormal Immune Response: Especially through hematopoietic stem cell transplantation (HSCT), which seeks to reconstruct the immune system after intense immunosuppression in properly chosen individuals.

Minimise Inflammation: The research is focusing on the potential benefits of using mesenchymal stem cells (MSCs), which may be useful due to their immunomodulatory capabilities and ability to decrease inflammation in multiple sclerosis.

Support Repair Mechanisms: Scientists continue to explore whether stem cells may help create a supportive environment for myelin repair, protect nerve cells, or promote recovery. However, these approaches still remain investigational and have not been established as proven clinical practices.

Improve Long-term Disease Management: Research is also underway to explore whether the use of stem cell therapies, along with conventional medicine, would affect the course of the disease and the health of the patients.

While this research has gathered considerable attention from scientists and patients, the results remain inconsistent between one research to another. The effectiveness of stem cell therapy depends on factors such as the type of stem cells used, stage of MS, and well-designed clinical trials. More high-quality research is needed before many of these approaches can become part of routine clinical practice.

Which Stem Cell Approaches Are Being Investigated for Multiple Sclerosis?

Stem cell research for MS does not focus solely on one type of stem cell. Different approaches are currently being studied for their different potential, and research continues to be conducted for selected patient groups. At present, scientists are focusing on two approaches that have received significant scientific attention.

Here are the two approaches:

Hematopoietic Stem Cell Transplantation (HSCT)

Hematopoietic stem cell transplantation focuses on rebuilding the immune system after heavy immunosuppressive therapy.
Researchers are studying whether this approach may reduce inflammatory disease activity and slow down progression in carefully selected patients with aggressive multiple sclerosis.

Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are still being studied for their immunomodulatory and anti-inflammatory properties.
Some studies are also exploring whether they may help create an environment that supports tissue repair in the body and protects nerve cells, although these approaches remain under investigation.

Even though the two methods employ stem cells, they are not equivalent in nature since they differ in terms of origin, mechanism of action, risk factors, and the scientific problems that each is meant to solve. For this reason, the findings obtained from one of the two stem cell treatments cannot be used in the other.

As further research progresses, efforts are being made to determine the patients who can benefit the most from these two types of treatment and when the optimal timing is to carry out the procedures.

What Have Clinical Studies Found So Far?

Research into stem cell therapy for multiple sclerosis has shown some encouraging findings in some areas, especially for some appropriate patients. However, the outcomes remain varied across all types of stem cell therapies or types of multiple sclerosis. Current evidence continues to grow, and researchers are still working to better understand which approach may be suitable.

Current findings include:

Reduced Disease Activity: Many studies on HSCT have demonstrated lower relapse rates and fewer new inflammatory lesions on MRI in patients with highly relapsing MS who had not responded well to conventional therapies.

Encouraging Safety Findings for MSCs: Some early clinical studies suggest that mesenchymal stem cells (MSCs) are usually well tolerated. Researchers continue to study whether their immunomodulatory properties may influence meaningful long-term clinical practices.

Variable Results Across Different Patient Groups: Patient responses vary depending on to treatment is administered. There may be variables that affect results, such as types of multiple sclerosis, phase of the disease, past treatments, and nature of the trial itself.

Need for Long-Term Evidence: While many positive results have been seen on a short-term basis, there is still a need for more large clinical trials and follow-up in order to gain a greater understanding of the safety, durability of effects, and correct protocol for use of stem cells.

From the existing scientific literature, it can be said that Current scientific evidence suggests meaningful progress has been made in stem cell therapy for multiple sclerosis. However, these approaches remain investigational for many applications, and treatment decisions should continue to be guided by the latest clinical evidence and specialist evaluation.

Looking Ahead

Stem cell research continues to improve our understanding to improve the understanding of multiple sclerosis. Although studies have shown encouraging findings for approaches such as HSCT and mesenchymal stem cells in controlled settings, these therapies remain investigational for many applications and should be considered within the context of current scientific evidence.

If you are considering a stem cell-based approach for MS, understanding both the potential and limitations of current research is important. Discussing your medical history, treatment goals, and the latest evidence with experienced specialists can help you make informed decisions that are appropriate for your individual condition.

Frequently Asked Questions

Q1. Is stem cell therapy approved for treating multiple sclerosis?

Most stem cell therapies for multiple sclerosis remain investigational. Treatment availability depends on local regulations, clinical evidence, and individual patient evaluation.

Q2. Can people with progressive multiple sclerosis participate in stem cell research?

Some clinical trials include patients with progressive MS, but eligibility depends on the study’s inclusion criteria and the individual’s medical condition.

Q3. How do researchers measure whether stem cell therapy is working?

Studies commonly evaluate relapse rates, MRI findings, disability progression, neurological function, and patient-reported quality of life over time.

Q4. Why do clinical trial results sometimes differ?

Results can vary because of differences in stem cell type, treatment protocols, patient selection, disease stage, and study design.

Q5. Where can patients find reliable information about stem cell research?

Trusted information is available through qualified healthcare professionals, peer-reviewed scientific publications, and registered clinical trial databases.

Reference Links

Muraro PA, Martin R, Mancardi GL, et al.

Autologous Haematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis: Recommendations From the EBMT and Joint Accreditation Committee of EBMT and ISCT. Nature Reviews Neurology. 2025.

Available at: https://www.nature.com/articles/s41582-024-01050-x

Petrou P, Kassis I, Levin N, et al.

Beneficial Effects of Autologous Mesenchymal Stem Cell Transplantation in Active Progressive Multiple Sclerosis. Brain. 2020.

Available at: https://academic.oup.com/brain/article/143/12/3574/5954042

Massey JC, Sutton IJ, Ma DDF.

Regenerative Cell Therapies for Multiple Sclerosis: Current Perspectives and Future Directions. International Journal of Molecular Sciences. 2021.

Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8469902/

International Society for Stem Cell Research (ISSCR).

The ISSCR Guide to Stem Cell Treatments. 2024.

Available at: https://www.isscr.org/s/ISSCR_PatientHandbook_v12_Feb2024_Redesign_v4b.pdf

Indian Council of Medical Research (ICMR) & Department of Biotechnology (DBT).

National Guidelines for Stem Cell Research. 2017.

Available at: https://main.icmr.nic.in/sites/default/files/guidelines/Guidelines_for_Stem_Cell_Research_2017.pdf

Medical Disclaimer: This blog is intended for educational purposes only and should not be considered medical advice or a recommendation for treatment. Stem cell research for multiple sclerosis is an evolving field, and many stem cell-based therapies remain investigational. Treatment decisions should always be based on an individual’s medical condition, current scientific evidence, and consultation with a qualified healthcare professional.

Can Stem Cell Research Help Multiple Sclerosis?

Can Stem Cell Research Help Multiple Sclerosis?

Table of Contents

Key Takeaways